Adrenalin (Epinephrine) Patent Expiration, LOE Window & CMS Spending

Adrenalin (Epinephrine) by Ph Health: FDA Orange Book LOE 2035-03-13, 1 AB generics, $7.7M 2024 CMS Part D & Medicaid spend, and 1 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorPh Health
FDA Application & PathwayN204200 (NDA)
Exclusivity / Cliff HorizonMid-Term Protection (2031-2035)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2035-03-13
Orange Book Patents (*PED Extensions)3 patents (0 *PED)
Active AB-Rated Generic Competitors1
2024 CMS Total Public Spend$7.7M
2024 Medicare Part D Spend$61K
2024 Medicaid Spend$7.6M
Reported Wholesale Price Change (CA SB 17)1 WAC filings (max 50.0% 2-yr change)